IND-ENABLING DEVELOPMENT OF SELECTIVE INHIBITORS OF NAV1.7

$1,004,267FY2017Department of the ArmyDOD

Siteone Therapeutics, Inc., South San Francisco CA

Investigators

View source on USAspending →